ColdZyme® protects airway epithelia from infection with BA.4/5

Vaccines against SARS-CoV-2 protect from critical or severe pathogenesis also against new variants of concern (VOCs) such as BA.4 and BA.5, but immediate interventions to avoid viral transmission and subsequent inflammatory reactions are needed. Here we applied the ColdZyme® medical device mouth spr...

Descripción completa

Detalles Bibliográficos
Autores principales: Viktoria, Zaderer, Stefanie, Dichtl, Rosa, Bellmann-Weiler, Cornelia, Lass-Flörl, Wilfried, Posch, Doris, Wilflingseder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624019/
https://www.ncbi.nlm.nih.gov/pubmed/36316674
http://dx.doi.org/10.1186/s12931-022-02223-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624019/
https://www.ncbi.nlm.nih.gov/pubmed/36316674
http://dx.doi.org/10.1186/s12931-022-02223-2

Ejemplares similares